Tilray (NASDAQ:TLRY) Shares Up 1.1% – Should You Buy?

Tilray Inc (NASDAQ:TLRY) shares rose 1.1% on Wednesday . The company traded as high as $1.59 and last traded at $1.59. Approximately 2,834,035 shares were traded during mid-day trading, a decline of 89% from the average daily volume of 25,168,512 shares. The stock had previously closed at $1.57.

Analysts Set New Price Targets

Separately, Roth Mkm decreased their price target on shares of Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a report on Friday, October 11th.

Tilray Stock Up 1.3 %

The stock has a market capitalization of $1.23 billion, a price-to-earnings ratio of -3.60 and a beta of 2.13. The company has a quick ratio of 1.57, a current ratio of 2.47 and a debt-to-equity ratio of 0.08. The stock has a 50 day moving average price of $1.74 and a 200 day moving average price of $1.84.

Tilray (NASDAQ:TLRY) last posted its earnings results on Thursday, October 10th. The company reported ($0.04) EPS for the quarter, hitting the consensus estimate of ($0.04). Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The business had revenue of $200.00 million for the quarter, compared to the consensus estimate of $218.70 million. During the same period last year, the company earned ($0.10) EPS. The firm’s revenue was up 13.0% compared to the same quarter last year. As a group, analysts forecast that Tilray Inc will post -0.18 EPS for the current year.

Institutional Trading of Tilray

Institutional investors and hedge funds have recently bought and sold shares of the stock. Prospect Financial Services LLC acquired a new position in Tilray during the 2nd quarter worth about $26,000. Signature Estate & Investment Advisors LLC acquired a new position in shares of Tilray in the second quarter worth approximately $29,000. Jeppson Wealth Management LLC acquired a new stake in Tilray during the 2nd quarter valued at approximately $33,000. Vanguard Capital Wealth Advisors bought a new position in Tilray during the 2nd quarter worth approximately $34,000. Finally, HBK Sorce Advisory LLC acquired a new position in shares of Tilray in the 1st quarter worth approximately $37,000. 9.35% of the stock is currently owned by institutional investors and hedge funds.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.